Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies
Natsumi Kawasaki(Chugai Pharma (United States)), Yasushi Yoshimura
Cited by 11
Related Papers
TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling
|Cell Discovery|2018|76